Research HighlightsResearch

Neurology Update: Dementia and cognitive disorders

February 18, 2021

Longitudinal neuroimaging biomarkers differacross Alzheimer’s disease phenotypes

Sintini et al investigated whether baseline and longitudinal patterns of tau-PET uptake and MRI grey matter volume loss mirror clinical phenotype in Alzheimer’s disease.

Read more here.

You may also like

Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])

May 5, 2021

COVID-19 in teriflunomide-treated patients with multiple sclerosis: A case report and literature review

February 3, 2021

RRFS Special Session – Unveiling research in Neurology: differences between basic, clinical and translational

June 25, 2022

Activities of the Subspeciality Scientific Panel on Dementia and Cognitive Disorders Panel 2016-2017 

October 9, 2017

European Journal of Neurology: November issue online!

October 17, 2018

Underdetection of COVID-19 cases in France threatens epidemic control

January 5, 2021

Clinical Practice Guidelines for Rare Diseases: development and quality assessment

November 1, 2018

Tackling challenges in care of Alzheimer’s disease and other dementias amid the COVID-19 pandemic, now and in the future

October 16, 2020

Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hospitalized with COVID-19: A Single Health System Study

September 1, 2020

Increasing transparency: publication of the development and launch process for the EAN guideline prioritisation procedure

November 21, 2022

Leave a Comment